These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 4101700)

  • 21. The assessment of medical treatment for benign prostatic hyperplasia (BPH).
    Roehrborn CG
    Prog Clin Biol Res; 1994; 386():175-90. PubMed ID: 7528385
    [No Abstract]   [Full Text] [Related]  

  • 22. Phytotherapeutic agents in the management of symptomatic benign prostatic hyperplasia.
    Fitzpatrick JM; Lynch TH
    Urol Clin North Am; 1995 May; 22(2):407-12. PubMed ID: 7539185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Status of phytotherapeutic drugs in treatment of benign prostatic hyperplasia].
    Dreikorn K; Schönhöfer PS
    Urologe A; 1995 Mar; 34(2):119-29. PubMed ID: 7538709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pygeum.
    McQueen CE; Bryant PJ
    Am J Health Syst Pharm; 2001 Jan; 58(2):120-3. PubMed ID: 11202534
    [No Abstract]   [Full Text] [Related]  

  • 25. [Safety of continuous (more than 1 year) intake of Serenoa repens extract by patients with prostatic adenoma].
    Vinarov AZ; Aliaev IuG; Lokshin KL
    Urologiia; 2009; (1):84, 86-7. PubMed ID: 19432240
    [No Abstract]   [Full Text] [Related]  

  • 26. [Influence of dihydrotestosterone deficit on treatment of prostatic diseases regarding to contemporary methods of prostatic hypertrophy treatments].
    Laszczyńska M; Chorzepa-Nowicka K; Wylot M; Piasecka M; Gaczarzewicz D
    Pol Merkur Lekarski; 2008 Dec; 25(150):528-30. PubMed ID: 19205388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Benign prostatic hyperplasia. Therapeutic possibilities].
    Pannek J; Haupt G; Schulze H
    Med Monatsschr Pharm; 1994 Aug; 17(8):237-46. PubMed ID: 7523841
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical experimentation with V 1326 in prostatic disorders].
    Lange ; Muret
    Bord Med; 1970 Nov; 3(11):2807-8 passim. PubMed ID: 4101700
    [No Abstract]   [Full Text] [Related]  

  • 29. [Drug treatment options in prostatic hyperplasia].
    Hauri D
    Praxis (Bern 1994); 1997 Sep; 86(38):1463-6. PubMed ID: 9381047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Botulinum-A toxin: an exciting new treatment option for prostatic disease.
    Thomas CA; Guercini F; Chuang YC; Chancellor MB
    Int J Clin Pract Suppl; 2006 Dec; (151):33-7. PubMed ID: 17169009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis and management of benign prostatic hyperplasia.
    Edwards JL
    Am Fam Physician; 2008 May; 77(10):1403-10. PubMed ID: 18533373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plant extracts: sense or nonsense?
    Madersbacher S; Berger I; Ponholzer A; Marszalek M
    Curr Opin Urol; 2008 Jan; 18(1):16-20. PubMed ID: 18090484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 2.